• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RUNX1/AML1无法突破AML1-ETO对胚胎干细胞定向造血的阻滞。

Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.

作者信息

Peterson Luke F, Lo Miao-Chia, Okumura Akiko Joo, Zhang Dong-Er

机构信息

Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Blood Cells Mol Dis. 2007 Nov-Dec;39(3):321-8. doi: 10.1016/j.bcmd.2007.06.012. Epub 2007 Aug 9.

DOI:10.1016/j.bcmd.2007.06.012
PMID:17692541
Abstract

The t(8;21)(q22:q22) translocation associated with acute myeloid leukemia fuses the AML1/RUNX1 N-terminal portion located on chromosome 21 to most of the ETO/MTG8 gene on chromosome 8. Various investigators have shown that the fusion product AML1-ETO on its own is unable to promote leukemia. Early studies using transgenic mouse models demonstrated that the direct knock-in of the fusion protein expression is embryonic lethal, similar to the AML1 knockout, suggesting that AML1-ETO has a dominant negative role over AML1. Using the embryonic stem cells generated for such studies, we show here that the presence of the fusion product AML1-ETO blocks definitive hematopoiesis in vitro as well, in both one and two step methylcellulose methods of embryonic stem cell hematopoietic differentiation. However, there is a very low occurrence of macrophage colonies, similar to the knock-in mice that display macrophages in cell cultures of yolk sac derived cells. In addition, we show that exogenous expression of AML1 is unable to bypass this AML1-ETO induced definitive hematopoietic block in these cells. This inability is not linked to an inability to reverse gene expression inhibition by AML1-ETO of the PU.1 gene associated with stem cell maintenance and myeloid differentiation. Our results suggest that AML1-ETO functions in a complex competitive manner with AML1 involving transcriptional regulation, protein-protein interactions and post-transcriptional mechanism(s) affecting early embryonic hematopoiesis and possibly leukemogenesis.

摘要

与急性髓系白血病相关的t(8;21)(q22:q22)易位将位于21号染色体上的AML1/RUNX1 N端部分与8号染色体上的大部分ETO/MTG8基因融合。多位研究者已表明,融合产物AML1-ETO自身无法促进白血病发生。早期使用转基因小鼠模型的研究表明,融合蛋白表达的直接敲入具有胚胎致死性,类似于AML1基因敲除,这表明AML1-ETO对AML1具有显性负性作用。利用为此类研究生成的胚胎干细胞,我们在此表明,在胚胎干细胞造血分化的一步和两步甲基纤维素方法中,融合产物AML1-ETO的存在也会在体外阻断确定性造血。然而,巨噬细胞集落的发生率非常低,类似于在卵黄囊来源细胞的细胞培养中显示巨噬细胞的敲入小鼠。此外,我们表明,AML1的外源性表达无法绕过这些细胞中由AML1-ETO诱导的确定性造血阻滞。这种无能与无法逆转AML1-ETO对与干细胞维持和髓系分化相关的PU.1基因的基因表达抑制无关。我们的结果表明,AML1-ETO与AML1以复杂的竞争方式发挥作用,涉及转录调控、蛋白质-蛋白质相互作用以及影响早期胚胎造血和可能的白血病发生的转录后机制。

相似文献

1
Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.RUNX1/AML1无法突破AML1-ETO对胚胎干细胞定向造血的阻滞。
Blood Cells Mol Dis. 2007 Nov-Dec;39(3):321-8. doi: 10.1016/j.bcmd.2007.06.012. Epub 2007 Aug 9.
2
Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.胚胎干细胞造血分化过程中AML/Runx和ETO/MTG家族成员的表达
Exp Hematol. 2007 Jun;35(6):978-88. doi: 10.1016/j.exphem.2007.03.002.
3
Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.AML1-ETO融合基因杂合小鼠的胚胎致死性和造血功能损伤。
Nat Genet. 1997 Mar;15(3):303-6. doi: 10.1038/ng0397-303.
4
The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.t(8;21)融合蛋白AML1/ETO可使NIH3T3细胞发生转化并激活AP-1。
Oncogene. 1999 Mar 4;18(9):1701-10. doi: 10.1038/sj.onc.1202459.
5
A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.一种先前未被识别的t(8;21)转录本的可变剪接异构体促进白血病发生。
Nat Med. 2006 Aug;12(8):945-9. doi: 10.1038/nm1443. Epub 2006 Jul 30.
6
Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.威廉姆斯-贝伦综合征关键区域5/非T细胞激活连接蛋白:一种AML1/ETO的新型靶基因。
Oncogene. 2004 Dec 2;23(56):9070-81. doi: 10.1038/sj.onc.1208042.
7
Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene.致白血病的AML1-ETO融合蛋白通过上调细胞色素P450-1A1基因的表达增加致癌物-DNA加合物的形成。
Exp Hematol. 2007 Aug;35(8):1249-55. doi: 10.1016/j.exphem.2007.04.018. Epub 2007 Jun 8.
8
Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.小鼠AML1/RUNX1基因转录本AML1c可变剪接形式的鉴定及其在早期造血发育中的表达。
Biochem Biophys Res Commun. 2001 Mar;281(5):1248-55. doi: 10.1006/bbrc.2001.4513.
9
Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.白血病相关因子AML1和p300在髓细胞分化中的相互作用及功能协作。
EMBO J. 1998 Jun 1;17(11):2994-3004. doi: 10.1093/emboj/17.11.2994.
10
AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation.AML1-ETO减少了ETO-2(MTG16)与核受体共抑制因子的相互作用,这种作用损害粒细胞分化。
Cancer Res. 2004 Jul 1;64(13):4547-54. doi: 10.1158/0008-5472.CAN-03-3689.

引用本文的文献

1
Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways.全面的基因组谱分析在糖尿病肾病中揭示了促炎途径的优势。
Physiol Genomics. 2013 Aug 15;45(16):710-9. doi: 10.1152/physiolgenomics.00028.2013. Epub 2013 Jun 11.
2
The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.人源 SWI/SNF 复合物与 RUNX1 结合,控制造血靶基因的转录。
J Cell Physiol. 2010 Nov;225(2):569-76. doi: 10.1002/jcp.22240.